Cargando…
A 98-Year-Old Male With Paroxysmal Atrial Fibrillation Treated for COVID-19 at Home
In the absence of evidenced-based guidelines for early home treatment of COVID-19, some Italian groups of volunteer physicians (both general practitioners (GPs) and hospital doctors) virtually gathered themselves to discuss the best available evidence and develop shared schemes of therapy. We presen...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681671/ https://www.ncbi.nlm.nih.gov/pubmed/36426345 http://dx.doi.org/10.7759/cureus.30653 |
_version_ | 1784834666708074496 |
---|---|
author | Farolfi, Fabrizia Cavazza, Stefania Mangiagalli, Andrea Cavanna, Luigi |
author_facet | Farolfi, Fabrizia Cavazza, Stefania Mangiagalli, Andrea Cavanna, Luigi |
author_sort | Farolfi, Fabrizia |
collection | PubMed |
description | In the absence of evidenced-based guidelines for early home treatment of COVID-19, some Italian groups of volunteer physicians (both general practitioners (GPs) and hospital doctors) virtually gathered themselves to discuss the best available evidence and develop shared schemes of therapy. We present the case of a 98-year-old unvaccinated male on chronic anticoagulant therapy with dabigatran for paroxysmal atrial fibrillation (AF), who has been successfully treated for COVID-19 at home, according to one of the multidrug treatments proposed, since hospital admission was not feasible. At the very beginning of symptoms, anti-inflammatory drugs, vitamin D, and adjuvant dietary supplements (quercetin, vitamin C, zinc, and vitamin K2) were administered, followed by dexamethasone and antibiotic therapy, according to the evolving clinical conditions. Gastroprotection with omeprazole was added. Eventually, our patient fully recovered, thus suggesting that careful home assistance under strict medical supervision can be successful, even in a very old subject with comorbidities, particularly if early treatment simultaneously addressing inflammation, hypercoagulation, and viral replication is started. |
format | Online Article Text |
id | pubmed-9681671 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-96816712022-11-23 A 98-Year-Old Male With Paroxysmal Atrial Fibrillation Treated for COVID-19 at Home Farolfi, Fabrizia Cavazza, Stefania Mangiagalli, Andrea Cavanna, Luigi Cureus Family/General Practice In the absence of evidenced-based guidelines for early home treatment of COVID-19, some Italian groups of volunteer physicians (both general practitioners (GPs) and hospital doctors) virtually gathered themselves to discuss the best available evidence and develop shared schemes of therapy. We present the case of a 98-year-old unvaccinated male on chronic anticoagulant therapy with dabigatran for paroxysmal atrial fibrillation (AF), who has been successfully treated for COVID-19 at home, according to one of the multidrug treatments proposed, since hospital admission was not feasible. At the very beginning of symptoms, anti-inflammatory drugs, vitamin D, and adjuvant dietary supplements (quercetin, vitamin C, zinc, and vitamin K2) were administered, followed by dexamethasone and antibiotic therapy, according to the evolving clinical conditions. Gastroprotection with omeprazole was added. Eventually, our patient fully recovered, thus suggesting that careful home assistance under strict medical supervision can be successful, even in a very old subject with comorbidities, particularly if early treatment simultaneously addressing inflammation, hypercoagulation, and viral replication is started. Cureus 2022-10-25 /pmc/articles/PMC9681671/ /pubmed/36426345 http://dx.doi.org/10.7759/cureus.30653 Text en Copyright © 2022, Farolfi et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Family/General Practice Farolfi, Fabrizia Cavazza, Stefania Mangiagalli, Andrea Cavanna, Luigi A 98-Year-Old Male With Paroxysmal Atrial Fibrillation Treated for COVID-19 at Home |
title | A 98-Year-Old Male With Paroxysmal Atrial Fibrillation Treated for COVID-19 at Home |
title_full | A 98-Year-Old Male With Paroxysmal Atrial Fibrillation Treated for COVID-19 at Home |
title_fullStr | A 98-Year-Old Male With Paroxysmal Atrial Fibrillation Treated for COVID-19 at Home |
title_full_unstemmed | A 98-Year-Old Male With Paroxysmal Atrial Fibrillation Treated for COVID-19 at Home |
title_short | A 98-Year-Old Male With Paroxysmal Atrial Fibrillation Treated for COVID-19 at Home |
title_sort | 98-year-old male with paroxysmal atrial fibrillation treated for covid-19 at home |
topic | Family/General Practice |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681671/ https://www.ncbi.nlm.nih.gov/pubmed/36426345 http://dx.doi.org/10.7759/cureus.30653 |
work_keys_str_mv | AT farolfifabrizia a98yearoldmalewithparoxysmalatrialfibrillationtreatedforcovid19athome AT cavazzastefania a98yearoldmalewithparoxysmalatrialfibrillationtreatedforcovid19athome AT mangiagalliandrea a98yearoldmalewithparoxysmalatrialfibrillationtreatedforcovid19athome AT cavannaluigi a98yearoldmalewithparoxysmalatrialfibrillationtreatedforcovid19athome AT farolfifabrizia 98yearoldmalewithparoxysmalatrialfibrillationtreatedforcovid19athome AT cavazzastefania 98yearoldmalewithparoxysmalatrialfibrillationtreatedforcovid19athome AT mangiagalliandrea 98yearoldmalewithparoxysmalatrialfibrillationtreatedforcovid19athome AT cavannaluigi 98yearoldmalewithparoxysmalatrialfibrillationtreatedforcovid19athome |